Embrace cutting-edge research, unlock untapped market potential, and address core challenges to drive growth and innovation in the treatment of mental health disorders.
The psychedelics venture capital industry is experiencing a dynamic change fueled by increasing scientific research and shifting societal attitudes. Clinical trials, innovative delivery methods, and mental health applications shape the psychedelics market, leading to more effective and accessible treatments. As the psychedelics sector adapts to these advancements, new possibilities for innovation and industry disruption arise. At Waveup, we discover such untapped opportunities in emerging and high-growth industries, including psychedelics, and leverage market intelligence to help our clients identify and build actionable blueprints for growth. With deep industry analytics at the core of our services, we provide end-to-end support in designing and executing growth projects – from fundraising to psychedelics M&A scouting and psychedelics market research. Whether you’re just looking for industry insights or interested in tailored support, we’re here to help you navigate the modern psychedelics landscape with confidence.
1/3
A 2022 survey indicated that psychedelics have been experienced by 28% of Americans.
5.5M+
In 2022, LSD use in the U.S. increased to 5.5+ million people.
Of patients with major depressive disorder experienced significant improvements after two sessions of psilocybin-assisted therapy.
Psilocybin mushrooms are decriminalized in 7 U.S. cities and 2 states.
Public interest in psychedelic therapy surged by 450% from 2018 to 2022, according to Google search trends.
VENTURE LANDSCAPE
With the majority of investment going to:
WAVEUP VIEW
Despite the transformative potential of psychedelics, industry players must remain vigilant of potential risks and challenges in order to succeed in the rapidly-evolving landscape.
Psychedelic substances require thorough research and clinical trials to ensure their safety and efficacy. This process can be time-consuming and expensive, potentially deterring investors. Startups must demonstrate a clear plan for navigating these research complexities to secure funds.
Psychedelics remain a controversial and widely misunderstood field. As such, startups often face the challenge of educating potential investors about the benefits and potential of psychedelic therapies, which should be clearly communicated in a psychedelics pitch deck.
Due to the controversial nature of psychedelic substances, startups need to work diligently on building public trust. Demonstrating commitment to safety, transparency, and ethical practices can further help startups gain investor trust and attract funding.
From diligent business analysis to storytelling and financial forecasts, we’re helping founders crystallize and structure key business fundamentals and translate them into compelling investment opportunities.
Evaluating potential investments, conducting thorough due diligence, and supporting portfolio companies on their new fundraising rounds.
Discovering market opportunities and developing execution strategies.
WHO WE ARE
Market intelligence
Fundraising support
Pitch decks
Financial models
Investor research
Growth consulting
Go-to-market strategies
Marketing/sales materials
Design support
Our unique value proposition lies in our constant exposure to new and developing sectors, powered by an unparalleled acumen at the intersection of cutting-edge business models, disruptive growth strategies, and the latest industry trends.